130 related articles for article (PubMed ID: 19068144)
1. Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells.
Weingart C; Nelson PJ; Krämer BK; Mack M
BMC Immunol; 2008 Dec; 9():72. PubMed ID: 19068144
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate A released from platelets blocks RANTES presentation on cell surfaces and RANTES-dependent firm adhesion of leukocytes.
Mack M; Pfirstinger J; Weber C; Weber KS; Nelson PJ; Rupp T; Maletz K; Brühl H; Schlöndorff D
Eur J Immunol; 2002 Apr; 32(4):1012-20. PubMed ID: 11920567
[TBL] [Abstract][Full Text] [Related]
3. CCL5 derived from platelets increases megakaryocyte proplatelet formation.
Machlus KR; Johnson KE; Kulenthirarajan R; Forward JA; Tippy MD; Soussou TS; El-Husayni SH; Wu SK; Wang S; Watnick RS; Italiano JE; Battinelli EM
Blood; 2016 Feb; 127(7):921-6. PubMed ID: 26647394
[TBL] [Abstract][Full Text] [Related]
4. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.
Chen C; Li J; Bot G; Szabo I; Rogers TJ; Liu-Chen LY
Eur J Pharmacol; 2004 Jan; 483(2-3):175-86. PubMed ID: 14729105
[TBL] [Abstract][Full Text] [Related]
5. Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage.
Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WMC; Singh S; Kufner A; Prado DS; Johny E; Cifuentes-Pagano E; Hawse WF; Dutta P; Pagano PJ; Ho J; Bruder-Nascimento T
Hypertension; 2024 Apr; 81(4):776-786. PubMed ID: 38240165
[TBL] [Abstract][Full Text] [Related]
6. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
7. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
8. Selective diapedesis of Th1 cells induced by endothelial cell RANTES.
Kawai T; Seki M; Hiromatsu K; Eastcott JW; Watts GF; Sugai M; Smith DJ; Porcelli SA; Taubman MA
J Immunol; 1999 Sep; 163(6):3269-78. PubMed ID: 10477596
[TBL] [Abstract][Full Text] [Related]
9. Rapid Internalization and Nuclear Translocation of CCL5 and CXCL4 in Endothelial Cells.
Dickhout A; Kaczor DM; Heinzmann ACA; Brouns SLN; Heemskerk JWM; van Zandvoort MAMJ; Koenen RR
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298951
[TBL] [Abstract][Full Text] [Related]
10. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
11. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
Longden J; Cooke EL; Hill SJ
Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
13. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
[TBL] [Abstract][Full Text] [Related]
15. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
16. The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis.
Chan O; Burke JD; Gao DF; Fish EN
J Biol Chem; 2012 Aug; 287(35):29406-16. PubMed ID: 22782897
[TBL] [Abstract][Full Text] [Related]
17. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.
von Hundelshausen P; Weber KS; Huo Y; Proudfoot AE; Nelson PJ; Ley K; Weber C
Circulation; 2001 Apr; 103(13):1772-7. PubMed ID: 11282909
[TBL] [Abstract][Full Text] [Related]
18. CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.
Cambien B; Richard-Fiardo P; Karimdjee BF; Martini V; Ferrua B; Pitard B; Schmid-Antomarchi H; Schmid-Alliana A
PLoS One; 2011; 6(12):e28842. PubMed ID: 22205974
[TBL] [Abstract][Full Text] [Related]
19. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.
Signoret N; Hewlett L; Wavre S; Pelchen-Matthews A; Oppermann M; Marsh M
Mol Biol Cell; 2005 Feb; 16(2):902-17. PubMed ID: 15591129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]